基于人群的慢阻肺筛查:圣乔治呼吸问卷在资源有限环境中的应用
在尼泊尔、秘鲁和乌干达筛查40岁以上成人,以支气管舒张后FEV1/FVC Z评分<-1.645定义慢阻肺,评估SGRQ的筛查性能。SGRQ单独筛查的AUC为0.77,联合呼气峰流速后AUC升至0.84,提示SGRQ可作为资源有限环境下慢阻肺的替代筛查工具。
要点
- SGRQ筛查慢阻肺的AUC为0.77,最佳阈值为10.75分。
- SGRQ联合呼气峰流速后AUC提升至0.84。
- 联合筛查(SGRQ≥12分和/或PEF低于性别阈值)阴性预测值达98%。
核心结论
- SGRQ是慢阻肺的替代筛查工具,联合PEF有助于在资源有限环境识别慢阻肺高危人群。
研究设计与样本
- 在尼泊尔Bhaktapur、秘鲁Lima和乌干达Nakaseke筛查40岁及以上成人,共10709人参与,最终分析10008人(94%)。
- 以支气管舒张后FEV1/FVC Z评分<-1.645定义慢阻肺,用ROC曲线评估SGRQ的判别性能并确定最佳阈值。
主要发现
- 筛查人群平均年龄56.3岁,男性49.7%,当前吸烟者15.4%。
- 慢阻肺患病率为9.5%;总人群平均SGRQ评分为7.9分(SD=11.9),慢阻肺患者为20.3分(SD=19.4),非慢阻肺者为6.6分(SD=9.9)。
- SGRQ筛查慢阻肺的AUC为0.77(95%CI 0.75-0.79),最佳阈值为10.75分。
- SGRQ联合按性别分层的支气管舒张前PEF后,AUC升至0.84(95%CI 0.82-0.85)。
- 联合筛查(SGRQ总分≥12分和/或男性PEF<400 L/min、女性PEF<250 L/min)的敏感性为91%,特异性为47%,阴性预测值为98%。
关键数值与推荐
- 慢阻肺定义:支气管舒张后FEV1/FVC Z评分<-1.645。
- SGRQ最佳筛查阈值为10.75分。
- 联合筛查阳性标准:SGRQ总分≥12分和/或支气管舒张前PEF男性<400 L/min、女性<250 L/min。
临床怎么用
- 在无法普及肺功能的资源有限地区,可用SGRQ问卷初筛慢阻肺高危人群。
- 联合SGRQ与呼气峰流速可提高筛查判别力,高阴性预测值有助于排除低风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Spirometry, although necessary for the diagnosis of chronic obstructive pulmonary disease (COPD), remains a scarce and costly resource worldwide. Screening questionnaires may help to bridge the diagnostic gap. Objectives: We evaluated the performance of the St. George's Respiratory Questionnaire (SGRQ) as a screening tool using spirometry-confirmed COPD as a gold standard. Methods: We screened adults aged 40 years and older for COPD in Bhaktapur, Nepal; Lima, Peru; and Nakaseke, Uganda. Participants completed SGRQs and prebronchodilator peak expiratory flow (PEF). We defined COPD as a postbronchodilator FEV1/FVC Z-score less than -1.645, evaluated the discriminative performance of the SGRQ using receiver operating characteristic curves, and identified the best threshold to screen for spirometry-confirmed COPD. Measurements and Main Results: We screened 10,709 participants (mean age, 56.3 yr; 49.7% male; 15.4% current smokers). After exclusion for missing data and implausible values, we analyzed the data of 10,008 (94%) participants. Prevalence of spirometry-confirmed COPD was 9.5%; mean SGRQ scores were 7.9 points (SD = 11.9) for the total population, 20.3 points (SD = 19.4) for participants with COPD, and 6.6 points (SD = 9.9) for participants without COPD. The area under the curve for SGRQ as a screening tool for COPD was 0.77 (95% confidence interval, 0.75-0.79), and the best threshold was 10.75 points. When the SGRQ was combined with prebronchodilator PEF stratified by sex, the area under the curve increased to 0.84 (95% confidence interval, 0.82-0.85). A screening test that combined a total SGRQ score of 12 points and higher and/or prebronchodilator PEF <400 L/min for men and <250 L/min for women yielded a sensitivity of 91%, a specificity of 47%, and negative predictive value of 98% to identify spirometry-confirmed COPD. Conclusions: SGRQ is an alternative screening tool for spirometry-confirmed COPD. Screening with the SGRQ in combination with PEF may help to identify people at risk for COPD in resource-limited settings where spirometry is not readily available.
引用
- Checkley W, Yang M, Robertson NM, et al. Population-Based Screening for Chronic Obstructive Pulmonary Disease Using the St. George's Respiratory Questionnaire in Resource-Limited Settings. Am J Respir Crit Care Med. 2025. PMID: 40068167. doi:10.1164/rccm.202409-1862OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。